ArticleMolecular neurodegeneration2017

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency.

Michael G Agadjanyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.